Klasifikace Ph- MPO, histologie
T.Barbui, J.Thiele, A.M. Vannucchi, A. Tefferi
Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia
Leukemia 2013;27:1953–1958
T. Buhr,K. Hebeda,V. Kaloutsi,A. Porwit, J. V. der Walt,H. Kreipe
European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis
Haematologica 2012;97(3):360-365
T.Buhr, K. Hebeda, V. Kaloutsi, A.Porwit, J.V. der Walt, H. Kreipe
European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis
Haematologica 2012;97(3):360-5 – Reply
R. Burkhardt,R. Bartl,K. Jager,B. Frisch,G. Kettner,G. Mahl
Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings
Am J Clin Pathol 2011;136:618-624
S. M. Koopmans, F. J. Bot, K. H. Lam, A. M.W. van Marion, H. de Raeve, K.M. Hebeda
Reproducibility of Histologic classification in Nonfibrotic Myeloproliferative Neoplasia
Am J Clin Pathol 2011;136:618-624
J.J. Michiels
Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia
The Hematology Journal (2004) 5, 93–102
J.J. Michiels , H. De Raeve , K. Hebeda , K.H. Lam, Z.Berneman, W.Schroyens , J. Schwarz
WHO bone marrow features and European clinical,molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders
Leukemia Research 31 (2007) 1031–1038
J.Schwarz, M.Penka, K.Indrák, D.Pospíšilová, R. Pytlík, P.Dulíček
The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group
Leukemia (2008) 22, 2118–2119
J. L. Spivak , R. T. Silver
The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal
Blood 2008 112: 231-239
A. Tefferi, J. Thiele, A. Orazi, H. M. Kvasnicka, T. Barbui, C. A. Hanson
Proposals and rationale for revision of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations an ad hoc international expert panel
Blood 2007;110:1092-1097
L. Teofili, F. Giona, M. Martini, T. Cenci, F. Guidi, L. Torti
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia
Blood 2007;110:3384-3386
J. Thiele, A. Orazi, H.M.Kvasnicka, V. Franco, E. Boveri, U. Gianelli
European Bone Marrow Working Group trial on reproducibility of WHO criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis
Haematologica 2012;97(3):360-5 – Comment
J. Thiele. H. M. Kvasnicka, F. Facchetti, V. Franco, J. van der Walt, A. Orazi
European consensus on grading bone marrow fibrosis and assessment of cellularity
Haematologica 2005; 90:1128-1132
J. W. Vardiman, N.L. Harris, R.D. Brunning
The WHO classification of the myeloid neoplasms
Blood 2002;100:2292-2302